A new survey finds that nearly 12% of Americans—about 1 in 8—have tried Ozempic or similar GLP-1 weight loss medications. These drugs, including Wegovy, mimic natural hormones to help control appetite and blood sugar, leading to significant weight loss. Despite their popularity, side effects like nausea and cost barriers cause many to stop treatment early. However, adherence is improving, with more people sticking to these medications longer for better results. Watch this video to learn the latest trends, benefits, and challenges around GLP-1 drugs in 2025.
#SciencePulse #Ozempic #WeightLoss #GLP1 #Wegovy #HealthNews #WeightLossDrugs #DiabetesTreatment #MedicalNews2025 #Obesity #Science


🔊 LIKE ➡ SHARE ➡ SUBSCRIBE

Download the Asianet News App now!

Available on Android & iOS

👉 Android:
https://play.google.com/store/apps/details?id=com.vserv.asianet&hl=en_IN

👉 iOS:
https://apps.apple.com/in/app/asianet-news-official/id1093450032

For More Updates:

Follow us on our What's app Channel: https://whatsapp.com/channel/0029Va5Bq3yKwqSLSQTxam0r

English: https://newsable.asianetnews.com/

Hindi: https://hindi.asianetnews.com/

Malayalam: https://www.asianetnews.com/

Kannada: https://kannada.asianetnews.com/

Tamil: https://tamil.asianetnews.com/

Telugu: https://telugu.asianetnews.com/

Bengali: https://bangla.asianetnews.com/

Like us on Facebook: https://www.facebook.com/AsianetNewsa...

Follow us on Twitter: https://twitter.com/AsianetNewsEN

Follow us on Instagram: https://www.instagram.com/ann.newsable/

➡ If you like our video, give us a thumbs up and subscribe to our channel to get the daily dosage of news, entertainment, sports and more.